271 related articles for article (PubMed ID: 10896206)
1. Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.
Choi JY; Kim SE; Shin HJ; Kim BT; Kim JH
J Neurooncol; 2000; 46(1):63-70. PubMed ID: 10896206
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of brain tumors by simultaneous dual isotope SPECT with 201Tl-chloride and 99mTc-MIBI].
Nagai H; Yamasaki T; Yamamoto Y; Takada D; Miyazaki T; Sugimoto K; Matsumoto Y; Akiyama Y; Moritake K
No Shinkei Geka; 2004 Oct; 32(10):1029-37. PubMed ID: 15529789
[TBL] [Abstract][Full Text] [Related]
5. Uptake of 99mTc-tetrofosmin, 99mTc-MIBI and 201Tl in malignant thymoma.
Hashimoto T; Goto K; Hishinuma Y; Yachuda K; Sugioka Y; Arai K; Harada S; Goto M
Ann Nucl Med; 2000 Aug; 14(4):293-8. PubMed ID: 11023030
[TBL] [Abstract][Full Text] [Related]
6. The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma--a comparative study with 201Tl.
Nagamachi S; Jinnouchi S; Nabeshima K; Nishii R; Flores L; Kodama T; Kawai K; Tamura S; Yokogami K; Samejima T; Wakisaka S
Neuroradiology; 2001 Dec; 43(12):1023-30. PubMed ID: 11792039
[TBL] [Abstract][Full Text] [Related]
7. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
[TBL] [Abstract][Full Text] [Related]
8. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
9. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of 99mTc-hexakis 2-methoxy-2-isobutyl isonitrile and 201Tl SPECT imaging for evaluation of coronary artery disease].
Takahashi N; Tamaki N; Ohtani H; Shindo M; Kawamoto M; Yonekura Y; Ono S; Nohara R; Kambara H; Kawai C
Kaku Igaku; 1991 Sep; 28(9):1021-7. PubMed ID: 1837570
[TBL] [Abstract][Full Text] [Related]
11. [Comparative evaluation of 99mTc-MIBI (hexakis2-methoxy isobutyl isonitrile) and 201Tl-chloride in primary lung cancer].
Yamamoto Y; Kawasaki Y; Nishiyama Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Kumazawa Y; Fujita J; Tanabe M
Kaku Igaku; 1996 May; 33(5):501-11. PubMed ID: 8699618
[TBL] [Abstract][Full Text] [Related]
12. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 201Tl-chloride SPECT with 99mtc-MIBI SPECT in the depiction of malignant head and neck tumors.
Tomura N; Watanabe O; Takahashi S; Sakuma I; Otani T; Nishin T; Watarai J
Ann Nucl Med; 2006 Feb; 20(2):107-14. PubMed ID: 16615419
[TBL] [Abstract][Full Text] [Related]
14. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
15. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
16. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose.
Matsunari I; Böning G; Ziegler SI; Nekolla SG; Stollfuss JC; Kosa I; Ficaro EP; Schwaiger M
J Am Coll Cardiol; 1998 Oct; 32(4):927-35. PubMed ID: 9768713
[TBL] [Abstract][Full Text] [Related]
17. Comparison between rest technetium-99m-tetrofosmin and rest-redistribution thallium-201 SPECT in stable patients with healed myocardial infarction.
Kula M; Tutus A; Abaci A; Oguzhan A; Arslan SM; Ergin A
Nucl Med Commun; 2001 Dec; 22(12):1317-24. PubMed ID: 11711902
[TBL] [Abstract][Full Text] [Related]
18. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer.
Amano S; Inoue T; Tomiyoshi K; Ando T; Endo K
J Nucl Med; 1998 Aug; 39(8):1424-7. PubMed ID: 9708521
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
Fan YX; Luo RC; Li GP; Zheng H; Huang K
Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
[TBL] [Abstract][Full Text] [Related]
20. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
